Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Allais G, Benedetto C.

Drug Des Devel Ther. 2016 Oct 3;10:3225-3236. eCollection 2016. Review.

2.

The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.

Allais G, Rolando S, De Lorenzo C, Benedetto C.

Expert Rev Neurother. 2014 Aug;14(8):867-77. doi: 10.1586/14737175.2014.940901.

PMID:
25056381
3.

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.

Allais G, Tullo V, Cortelli P, Barbanti P, Valguarnera F, Sette G, D'Onofrio F, Curone M, Zava D, Pezzola D, Reggiardo G, Omboni S, Frediani F, Bussone G, Benedetto C.

Neurol Sci. 2014 May;35 Suppl 1:107-13. doi: 10.1007/s10072-014-1751-3.

4.

Frovatriptan: a review of its use in the acute treatment of migraine.

Sanford M.

CNS Drugs. 2012 Sep 1;26(9):791-811. doi: 10.2165/11209380-000000000-00000. Review.

PMID:
22900951
5.

Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Allais G, Tullo V, Omboni S, Pezzola D, Zava D, Benedetto C, Bussone G.

Neurol Sci. 2013 May;34 Suppl 1:S83-6. doi: 10.1007/s10072-013-1393-x.

6.

Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.

Tullo V, Valguarnera F, Barbanti P, Cortelli P, Sette G, Allais G, d'Onofrio F, Curone M, Zava D, Pezzola D, Benedetto C, Frediani F, Bussone G.

Cephalalgia. 2014 May;34(6):434-45. doi: 10.1177/0333102413515342. Epub 2013 Dec 20. Erratum in: Cephalalgia. 2015 Mar;35(3):286. Cephalalgia. 2015 Mar;35(3):286.

PMID:
24363238
7.

Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.

Tullo V, Bussone G, Omboni S, Barbanti P, Cortelli P, Curone M, Peccarisi C, Benedetto C, Pezzola D, Zava D, Allais G.

Neurol Sci. 2013 May;34 Suppl 1:S87-91. doi: 10.1007/s10072-013-1367-z. Review.

PMID:
23695053
8.

Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.

Savi L, Mogavero S, Egan CG.

Drug Des Devel Ther. 2014 Jul 21;8:983-92. doi: 10.2147/DDDT.S61295. eCollection 2014.

9.

Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.

Guidotti M, Ravasio R.

Clin Drug Investig. 2009;29(11):693-702. doi: 10.2165/11315330-000000000-00000. Review.

PMID:
19813772
10.

Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.

Franconi F, Finocchi C, Allais G, Omboni S, Tullo V, Campesi I, Reggiardo G, Benedetto C, Bussone G.

Neurol Sci. 2014 May;35 Suppl 1:99-105. doi: 10.1007/s10072-014-1750-4. Review.

11.

Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.

Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, Frediani F, D'Arrigo G, d'Onofrio F, Comi G, Curone M, Colombo B, Omboni S, Benedetto C.

Neurol Sci. 2015 May;36 Suppl 1:161-7. doi: 10.1007/s10072-015-2165-6. Erratum in: Neurol Sci. 2016 Feb;37(2):331.

PMID:
26017535
12.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Dec;12(6):609-15. doi: 10.1007/s10194-011-0366-9. Epub 2011 Aug 13.

13.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G.

Neurol Sci. 2011 May;32 Suppl 1:S99-104. doi: 10.1007/s10072-011-0547-y.

14.

Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.

Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F.

J Headache Pain. 2012 Jul;13(5):401-6. doi: 10.1007/s10194-012-0455-4. Epub 2012 May 17.

15.

Efficacy of frovatriptan as compared to other triptans in migraine with aura.

Evers S, Savi L, Omboni S, Lisotto C, Zanchin G, Pinessi L.

J Headache Pain. 2015;16:514. doi: 10.1186/s10194-015-0514-8. Epub 2015 Apr 1.

16.

Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.

Saracco MG, Allais G, Tullo V, Zava D, Pezzola D, Reggiardo G, Omboni S, Benedetto C, Bussone G, Aguggia M.

Neurol Sci. 2014 May;35 Suppl 1:115-9. doi: 10.1007/s10072-014-1752-2. Review.

PMID:
24867847
17.

Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.

Lisotto C, Guidotti M, Zava D, Savi L.

J Headache Pain. 2013 Dec 11;14:96. doi: 10.1186/1129-2377-14-96.

18.

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Apr;12(2):219-26. doi: 10.1007/s10194-010-0243-y. Epub 2010 Aug 5.

19.

Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ.

Cephalalgia. 2014 Apr;34(4):258-67. doi: 10.1177/0333102413508661. Epub 2013 Oct 9.

PMID:
24108308
20.

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.

Cady RK, Banks J, Jones BA, Campbell J.

Curr Med Res Opin. 2009 Nov;25(11):2711-21. doi: 10.1185/03007990903285449.

PMID:
19778164

Supplemental Content

Support Center